Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Levofloxacin for Cutaneous Leishmaniasis
NCT06797544Phase 2Recruiting
- Start
- Feb 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levofloxacin in cutaneous leishmaniasis (CL). Started Feb 2025; status: recruiting.
02
Drugs
levofloxacin
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT06797544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06797544.